Evidence map›Paper›PMID 41303240›Full record

ArticleJournal of clinical medicine2025

Complement Inhibitors in Generalized Myasthenia Gravis: Comparison of Administration Schedules, Efficacy, and Safety.

Giuseppe Di Martino, Nicasio Rini, Alessia Bonaventura, Mauro Trovato, Simona Maccora, Salvatore Maria Lima, Concetta La Seta, Filippo Brighina, Vincenzo Di Stefano

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giuseppe Di MartinoDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90129 Palermo, Italy.
Nicasio RiniDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90129 Palermo, Italy.
Alessia BonaventuraDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90129 Palermo, Italy.
Mauro TrovatoDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90129 Palermo, Italy.
Simona MaccoraDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90129 Palermo, Italy.ORCID 0000-0002-3068-0356
Salvatore Maria LimaDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90129 Palermo, Italy.ORCID 0009-0001-0021-3300
Concetta La SetaUnità Operativa Complessa Farmacia, Azienda Universitaria Ospedaliera Policlinico P. Giaccone Hospital, 90129 Palermo, Italy.
Filippo BrighinaDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90129 Palermo, Italy.ORCID 0000-0001-5875-3126
Vincenzo Di StefanoDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90129 Palermo, Italy.ORCID 0000-0001-9805-1655

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AChRcomplement inhibitorEculizumabMyasthenia GravisRavulizumabZilucoplan

Identifiers

PMID41303240
PMCPMC12653392

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.